Previous studies demonstrated that the exogenous intrathecal administration of IL-1β induced obvious pain behaviours5, whereas the blockade of spinal IL-1β signalling relieved nerve injury-induced neuropathic pain6, supporting a crucial role for spinal IL-1β in the development of neuropathic pain. This evidence concerns the gene IL1B and neuropathic pain.